We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.79%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$30M
Cap. Flow
-$33.2M
Cap. Flow %
-21.62%
Top 10 Hldgs %
41.01%
Holding
85
New
17
Increased
10
Reduced
29
Closed
24

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$5.56M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.98M
3
AKCA
Akcea Therapeutics Inc
AKCA
+$1.96M
4
PBYI icon
Puma Biotechnology
PBYI
+$1.96M
5
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$1.93M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$5.61M
2
AET
Aetna Inc
AET
+$4.53M
3
LLY icon
Eli Lilly
LLY
+$3.42M
4
GKOS icon
Glaukos
GKOS
+$3.3M
5
XLRN
Acceleron Pharma
XLRN
+$2.61M

Sector Composition

Rank Sector Weight
1 Healthcare 81.64%
2 Energy 0.6%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYOK
26
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.1M 1.37%
+50,000
New +$1.93M
IONS icon
27
Ionis Pharmaceuticals
IONS
$9.46B
$2.01M 1.31%
40,000
+25,000
+167% +$1.37M
SUPN icon
28
Supernus Pharmaceuticals
SUPN
$2.74B
$1.99M 1.3%
+50,000
New +$1.98M
MRUS
29
DELISTED
Merus
MRUS
$1.94M 1.26%
100,000
-40,000
-29% -$677K
ADMA icon
30
ADMA Biologics
ADMA
$2.18B
$1.93M 1.25%
600,000
+35,000
+6% +$97.9K
PFE icon
31
Pfizer
PFE
$154B
$1.81M 1.18%
52,700
-10,540
-17% -$359K
WVE icon
32
Wave Life Sciences
WVE
$1.2B
$1.75M 1.14%
50,000
-5,000
-9% -$146K
AKCA
33
DELISTED
Akcea Therapeutics Inc
AKCA
$1.74M 1.13%
+100,000
New +$1.96M
PBYI icon
34
Puma Biotechnology
PBYI
$442M
$1.73M 1.13%
+17,500
New +$1.96M
CLVS
35
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$1.7M 1.11%
25,000
-50,000
-67% -$3.5M
ARNA
36
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.7M 1.11%
50,000
-10,000
-17% -$285K
VTRS icon
37
Viatris
VTRS
$18.7B
$1.69M 1.1%
+40,000
New +$1.53M
AVXS
38
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.66M 1.08%
15,000
-2,500
-14% -$251K
MDCO
39
DELISTED
Medicines Co
MDCO
$1.64M 1.07%
60,000
-40,000
-40% -$1.23M
AGN
40
DELISTED
Allergan plc
AGN
$1.64M 1.07%
+10,000
New +$1.79M
ABLX
41
DELISTED
Ablynx NV
ABLX
$1.62M 1.05%
+65,000
New +$1.47M
CTMX icon
42
CytomX Therapeutics
CTMX
$750M
$1.58M 1.03%
75,000
+5,000
+7% +$104K
BSX icon
43
Boston Scientific
BSX
$73.1B
$1.24M 0.81%
50,000
-75,000
-60% -$2.07M
CTLT
44
DELISTED
CATALENT, INC.
CTLT
$1.23M 0.8%
30,000
– –
GSK icon
45
GSK
GSK
$104B
$1.06M 0.69%
+24,000
New +$1.11M
DPLO
46
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1M 0.65%
50,000
-10,000
-17% -$197K
RGNX icon
47
Regenxbio
RGNX
$688M
$998K 0.65%
+30,000
New +$904K
INCY icon
48
Incyte
INCY
$24.6B
$947K 0.62%
+10,000
New +$1.05M
LHCG
49
DELISTED
LHC Group LLC
LHCG
$919K 0.6%
+15,000
New +$992K
VKTX icon
50
Viking Therapeutics
VKTX
$4.02B
$913K 0.59%
+225,000
New +$653K
1
2
3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2017 Portfolio in Review

As of Q4 2017, Iguana Healthcare Management held 85 positions worth $154M, down 16% from $184M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Iguana Healthcare Management withdrew a net $33.2M in Q4 2017, closing 24 positions and reducing 29 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 77% a quarter earlier, followed by Energy and Financials.

Against the trend, Iguana Healthcare Management opened a new position in Humana worth $5.58M.

  • Iguana Healthcare Management's largest Q4 2017 buy was Humana: 22,500 shares worth $5.58M.
  • Iguana Healthcare Management added most to Ionis Pharmaceuticals in Q4 2017, an estimated $1.37M increase.
  • Iguana Healthcare Management's biggest Q4 2017 reduction was Boston Scientific, cutting an estimated $2.07M.
  • Iguana Healthcare Management fully exited Alexion Pharmaceuticals in Q4 2017, selling an estimated $5.61M.
  • Iguana Healthcare Management's ten largest holdings make up 41% of its $154M portfolio in Q4 2017.
  • Iguana Healthcare Management opened 17 new positions and closed 24 in Q4 2017.
  • Iguana Healthcare Management's portfolio value fell 16% quarter-over-quarter to $154M.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.